APPLICATION
ANDA070032
TYPE
ANDA
ORIGINAL APPROVAL
1985-02-15
LATEST ACTION
2025-12-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
SULFAMETHOPRIM-DSDiscontinued
SULFAMETHOXAZOLE 800MG, TRIMETHOPRIM 160MG · TABLET · ORAL
Approval history
2025-12-15Labeling · Supplement 18 · standardAP
2025-12-15Labeling · Supplement 17 · standardAP
2022-09-22Labeling · Supplement 16 · standardAP
2022-09-22Labeling · Supplement 15 · standardAP
1995-05-10Manufacturing (CMC) · Supplement 14AP
1994-03-11Labeling · Supplement 13AP
1989-06-19Labeling · Supplement 12AP
1988-05-09Labeling · Supplement 11AP
1988-02-01Manufacturing (CMC) · Supplement 10AP
1987-04-08Manufacturing (CMC) · Supplement 9AP
1986-07-17Manufacturing (CMC) · Supplement 3AP
1986-05-29Manufacturing (CMC) · Supplement 5AP
1986-05-29Manufacturing (CMC) · Supplement 6AP
1985-02-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.